SG11202111960PA - Method for treating endometriosis-associated pain by using diaminopyrimidine compound - Google Patents

Method for treating endometriosis-associated pain by using diaminopyrimidine compound

Info

Publication number
SG11202111960PA
SG11202111960PA SG11202111960PA SG11202111960PA SG11202111960PA SG 11202111960P A SG11202111960P A SG 11202111960PA SG 11202111960P A SG11202111960P A SG 11202111960PA SG 11202111960P A SG11202111960P A SG 11202111960PA SG 11202111960P A SG11202111960P A SG 11202111960PA
Authority
SG
Singapore
Prior art keywords
days
compound
saturated
alkylene
snh
Prior art date
Application number
SG11202111960PA
Other languages
English (en)
Inventor
Yanping Zhao
Huai Huang
Hongjun Wang
Yuanyuan Jiang
Huining Liang
Ran An
Zhou Lan
Jin Wang
Liying Zhou
Yanan Liu
Original Assignee
Beijing Tide Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Tide Pharmaceutical Co Ltd filed Critical Beijing Tide Pharmaceutical Co Ltd
Publication of SG11202111960PA publication Critical patent/SG11202111960PA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202111960PA 2019-04-30 2020-04-29 Method for treating endometriosis-associated pain by using diaminopyrimidine compound SG11202111960PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2019085209 2019-04-30
PCT/CN2020/087689 WO2020221277A1 (zh) 2019-04-30 2020-04-29 二氨基嘧啶类化合物治疗子宫内膜异位相关的疼痛的方法

Publications (1)

Publication Number Publication Date
SG11202111960PA true SG11202111960PA (en) 2021-12-30

Family

ID=73028778

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111960PA SG11202111960PA (en) 2019-04-30 2020-04-29 Method for treating endometriosis-associated pain by using diaminopyrimidine compound

Country Status (12)

Country Link
US (1) US12605381B2 (https=)
EP (1) EP3960178B1 (https=)
JP (1) JP7663508B2 (https=)
KR (1) KR102935431B1 (https=)
CN (1) CN114007620B (https=)
AU (1) AU2020266947B2 (https=)
BR (1) BR112021021838A8 (https=)
CA (1) CA3138238A1 (https=)
MX (1) MX2021013347A (https=)
SG (1) SG11202111960PA (https=)
TW (1) TWI737285B (https=)
WO (1) WO2020221277A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7207634B2 (ja) 2017-11-01 2023-01-18 ベイジン タイド ファーマシューティカル カンパニー リミテッド P2x3及び/又はp2x2/3受容体アンタゴニスト、それを含む医薬組成物及びその使用
US20250032476A1 (en) * 2021-11-05 2025-01-30 The Regents Of The University Of California Alpha-2a adrenergic receptor modulators and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008104474A1 (en) * 2007-02-28 2008-09-04 F. Hoffmann-La Roche Ag Diaminopyrimidines
MA43821A (fr) * 2016-03-14 2018-11-28 Afferent Pharmaceuticals Inc Pyrimidines et variantes de celles-ci, et leurs utilisations
MA44489A (fr) 2016-03-25 2019-01-30 Afferent Pharmaceuticals Inc Pyrimidines et variants de celles-ci, et leurs utilisations
JP7207634B2 (ja) * 2017-11-01 2023-01-18 ベイジン タイド ファーマシューティカル カンパニー リミテッド P2x3及び/又はp2x2/3受容体アンタゴニスト、それを含む医薬組成物及びその使用
USD956213S1 (en) 2020-10-02 2022-06-28 Phillips-Medisize A/S Autoinjector

Also Published As

Publication number Publication date
BR112021021838A8 (pt) 2023-02-28
JP7663508B2 (ja) 2025-04-16
BR112021021838A2 (pt) 2022-01-04
KR20220008286A (ko) 2022-01-20
CN114007620B (zh) 2024-08-06
CA3138238A1 (en) 2020-11-05
EP3960178A1 (en) 2022-03-02
JP2022531570A (ja) 2022-07-07
US20220249478A1 (en) 2022-08-11
MX2021013347A (es) 2022-01-24
TW202106303A (zh) 2021-02-16
KR102935431B1 (ko) 2026-03-05
CN114007620A (zh) 2022-02-01
WO2020221277A1 (zh) 2020-11-05
EP3960178B1 (en) 2026-03-18
US12605381B2 (en) 2026-04-21
TWI737285B (zh) 2021-08-21
AU2020266947A1 (en) 2021-12-16
EP3960178A4 (en) 2023-01-25
AU2020266947B2 (en) 2025-10-09

Similar Documents

Publication Publication Date Title
AU2020305979A1 (en) Method for treating idiopathic pulmonary fibrosis
KR20210137086A (ko) 지방간 질환 및/또는 지방간염의 치료 방법
JPS62215527A (ja) アルツハイマー病治療薬
AU2022241458B2 (en) Use of phenoxypropylamine compounds to treat depression
SG11202111960PA (en) Method for treating endometriosis-associated pain by using diaminopyrimidine compound
EP2716302B1 (en) Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
JP2526059B2 (ja) 抗潰瘍剤
WO2024008044A1 (zh) 大环拟肽类蛋白酶抑制剂及其用途
RU2056416C1 (ru) Производные тиомочевины, фармацевтическая композиция и способ лечения
HK40062123A (en) Method for treating endometriosis-associated pain by using diaminopyrimidine compound
SG11202111877TA (en) Method for treating cough by using diaminopyrimidine compound
IL299985A (en) A method for treating graft-versus-Maschen disease caused by hematopoietic stem cell transplantation
US20040106671A1 (en) Remedies for vesical hyperesthesia
HK40063619A (en) Method for treating endometriosis-associated pain by using diaminopyrimidine compound
HK40063619B (zh) 二氨基嘧啶类化合物治疗子宫内膜异位相关的疼痛的方法
HK40086216A (en) Method for treating graft versus host disease caused by hematopoietic stem cell transplantation
HK40062124A (en) Method for treating cough by using diaminopyrimidine compound
JP2949366B2 (ja) 心臓疾患の予防または治療剤
EA009082B1 (ru) Агент для улучшения химиотерапии рака
JP2003267871A (ja) 放射線障害予防剤
JPWO2003068263A1 (ja) 高血圧症治療薬
Buschmann et al. Use of sodium channel blockers for the treatment of preterm labor
NL8006341A (nl) Voor roentgenstralen amorfe, fysiologisch toelaatbare zuuradditiezouten van ergotalkaloiden en dihydroer- gotalkaloiden, werkwijze voor de bereiding en toepas- sing daarvan in de therapie.
WO1997036588A2 (en) Use of 1,1-dialkyl-1,2,3,4-tetrahydroisoquinolines for the manufacture of a medicament for the treatment of psychosis and pain
JPWO2001010445A1 (ja) 神経障害治療剤